CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
1.210
-0.010 (-0.82%)
At close: Nov 13, 2026, 4:00 PM EST
1.320
+0.110 (9.09%)
After-hours: Nov 13, 2026, 7:45 PM EST
CalciMedica Market Cap
CalciMedica has a market cap or net worth of $8.26 million as of November 13, 2026. It is the 42,448th most valuable company in the world and the 5,660th biggest in the United States. Its market cap has decreased by 82.83% in one year.
Market Cap
8.26M
Enterprise Value
1.39M
1-Year Change
-82.83%
Global Rank
Country Rank
#5,660 United States
Category
ChartMarket Cap Chart
Since March 21, 2023, CalciMedica's market cap has decreased from $92.48M to $8.26M, a decrease of -91.07%. That is a compound annual growth rate of -48.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 8.26M | -91.30% |
| Dec 31, 2025 | 94.96M | 98.97% |
| Dec 31, 2024 | 47.73M | 193.54% |
| Dec 29, 2023 | 16.26M | -82.42% |
| Mar 21, 2023 | 92.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 9.39M |
| BioLineRx | 9.35M |
| Lexaria Bioscience | 9.27M |
| CytoMed Therapeutics | 9.19M |
| MetaVia | 8.80M |
| IN8bio | 8.25M |
| Longeveron | 8.23M |
| Vistagen Therapeutics | 7.93M |